Author affiliation key: R-resident, F-fellow, S-staff, A-alumni

Bromley- Claypool Room


Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal  Melanoma in 1310 Patients By Age
Michael Chang, MD (F), Lauren A. Davlin, MD, Li-Anne S. Lim, MD, Carol L. Shields, MD [Tumor]


Refractive Outcomes after Pars Plana Vitrectomy and Scleral Fixated Intraocular Lens with Gore-Tex Suture
Daniel Su, MD (F), John D. Stephens, MD, Anthony Obeid, MD, MPH, Omesh Gupta, MD, MBA [Retina]


Safe Dermolipoma Surgery
Christine L. Zolli, MD (A) [Oculoplastics] 


Photoreceptor Morphology and Correlation with Subretinal Fluid Chronicity Associated with Choroidal Nevus
Antonio Yaghy, MD (F), Lauren A. Dalvin, MD, Michael Yu, BS, Carol L. Shields, MD [Tumor] 


Intravitreal Melphalan for Vitreoretinal Lymphoma
Li-Anne S. Lim, MD (F), Lauren A. Dalvin, MD, Carol L. Shields, MD [Tumor] 


A Study of Clinical Characteristics and Outcomes in CCF Patients Treated by Anterior Trans Venous Embolization
Archana Srivivasan, MD (F), Ann P. Murchison, MD, MPH, Jurij R. Bilyk, MD [Oculoplastics]


Ballroom A


Predictors of Enucleation in Coats Disease: Analysis of 371 Eyes from 361 Patients at a Single Center
Sanika Udyaver,  BS (MS), Lauren A. Dalvin, MD, Li-Anne S. Lim, MD, Carol L. Shields, MD [Retina]


Management of Retinoblastoma in Older Children: Intra-Arterial Chemotherapy vs. Previous Treatment Eras
Evan B. Selzer, MD (MS), R. Joel Welch, MD, Carol L. Shields, MD [Tumor]


Photodynamic Therapy for Extra-Foveolar Choroidal Osteoma
Mehdi Mazloumi, MD, MPH (F), Lauren A. Dalvin, MD, Arman Mashayekhi, MD, Carol L. Shields, MD [Tumor]


Rhegmatogenous Retinal Detachment Following Intravitreal Injection of Anti-Vascular Endothelial Growth Factor
Philip Storey, MD, MPH (F), Maitri Pancholi, BA, Turner Wibbelsman, BS, Omesh Gupta, MD, MBA [Retina]


Factors Predictive of Retinal Detachment Resolution in Coats Disease
Chloe T L. Khoo, MD (F), Lauren A. Dalvin, MD, Li-Anne S. Lim, MD, Carol L. Shields, MD [Retina]


Uveal Metastasis: Survival Outcome of 2214 Tumors in 1111 Patients  Based on Primary Tumor Origin
Carol L. Shields, MD (A), Jerry A. Shields, MD, R. Joel Welch, MD, Kunal Malik, BA [Tumor]